Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Complexometric Titration Method Development – V 2.0

Posted on By

Analytical Method Development: Complexometric Titration Method Development – V 2.0

SOP for Complexometric Titration Method Development in AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/059/2025
Supersedes SOP/AMD/059/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

The purpose of this SOP is to establish a standard procedure for the development, optimization, and validation of complexometric titration methods for the quantitative analysis of metal ions in pharmaceutical raw materials, active ingredients,

and finished products.

2. Scope

This SOP applies to the Analytical Method Development (AMD) laboratory and is intended for complexometric titration techniques using EDTA or other ligands as titrants for the determination of calcium, magnesium, zinc, copper, and other metal ions.

3. Responsibilities

  • Analytical Chemist: Conducts titration trials, prepares reagents, performs method validation, and records results.
  • Reviewer: Reviews accuracy, reproducibility, and calculation records for compliance and completeness.
  • QA Representative: Ensures that the SOP follows GMP principles and supports regulatory expectations.
  • Head – AMD: Approves developed methods for QC use and regulatory filing.

4. Accountability

The Head of AMD is accountable for ensuring scientifically justified, accurate, and validated complexometric titration methods are implemented for metal ion determination in pharmaceutical substances.

See also  Analytical Method Development: Limit Test for Iron and Heavy Metals - V 2.0

5. Procedure

5.1 Selection of Complexometric Reaction

  1. Identify metal ions present in the test substance or formulation.
  2. Select appropriate chelating agent (commonly EDTA) and endpoint indicator.
  3. Examples:
    • Calcium & Magnesium – EDTA with Eriochrome Black T (EBT) at pH 10
    • Zinc – EDTA with Xylenol Orange at pH 5–6
    • Copper – EDTA with PAN indicator
  4. Document selection in Annexure-1: Reaction Justification Sheet.

5.2 Preparation and Standardization of Reagents

  1. Prepare 0.05 M or 0.1 M EDTA solution using disodium salt of EDTA.
  2. Standardize EDTA solution using known concentration of calcium carbonate or magnesium sulfate.
  3. Prepare buffer solutions:
    • Ammonia-Ammonium Chloride buffer (pH 10) for Ca/Mg
    • Acetate buffer (pH 5–6) for Zn/Cu
  4. Prepare and filter indicators as per required conditions (e.g., 0.5% EBT in ethanol).
  5. Record all preparation steps in Annexure-2: Reagent Preparation Log.

5.3 Sample Preparation

  1. Accurately weigh the sample containing the metal ion to be determined.
  2. Dissolve in suitable solvent (e.g., distilled water, dilute HCl).
  3. If necessary, remove interfering ions by masking agents (e.g., cyanide, triethanolamine).
  4. Adjust pH using appropriate buffer.
  5. Document all steps in Annexure-3: Sample Preparation Record.

5.4 Execution of Titration

  1. Transfer sample solution to a clean conical flask.
  2. Add buffer solution and indicator (e.g., EBT turns wine red in presence of Mg/Ca).
  3. Titrate with EDTA solution until endpoint is reached (color changes to blue in EBT).
  4. Perform blank and standard titrations for comparison.
  5. Repeat titrations in triplicate for statistical consistency.
  6. Record endpoint volumes and calculations in Annexure-4: Titration Worksheet.
See also  Analytical Method Development: Water Content Method Development (Karl Fischer) - V 2.0

5.5 Calculation

Metal content (%) = (V × M × Eq. Wt × 100) / W × 1000
Where:
V = Volume of EDTA used (mL)
M = Molarity of EDTA
Eq. Wt = Equivalent weight of analyte (e.g., Ca = 20.04)
W = Sample weight (mg)

5.6 Method Optimization

  1. Evaluate:
    • Buffer pH impact on endpoint sharpness
    • Indicator concentration and color transition range
    • Interference from co-existing ions
  2. Conduct trials using known standards and observe endpoint stability.
  3. Document observations in Annexure-5: Optimization Record.

5.7 Method Validation

  1. Specificity: Demonstrate absence of interference from excipients or other metal ions.
  2. Linearity: Analyze standards at 50–150% concentration; R² ≥ 0.999.
  3. Accuracy: Recovery from spiked samples should be within 98–102%.
  4. Precision:
    • Repeatability: RSD ≤ 2.0% for six replicates
    • Intermediate Precision: Reproducibility on different days/analysts
  5. Robustness: Test minor variations in pH, temperature, and buffer strength.
  6. Record outcomes in Annexure-6: Validation Summary Report.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • EDTA: Ethylenediaminetetraacetic Acid
  • RSD: Relative Standard Deviation
  • EBT: Eriochrome Black T
  • AMD: Analytical Method Development

7. Documents

  1. Reaction Justification Sheet – Annexure-1
  2. Reagent Preparation Log – Annexure-2
  3. Sample Preparation Record – Annexure-3
  4. Titration Worksheet – Annexure-4
  5. Optimization Record – Annexure-5
  6. Validation Summary Report – Annexure-6
See also  Analytical Method Development: Review and Approval of Method Development Data - V 2.0

8. References

  • USP <541> – Titrimetry
  • IP Appendix 3.5 – Complexometric Methods
  • Ph. Eur. 2.2.20 – Potentiometric Titrations
  • ICH Q2(R1) – Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Reaction Justification Sheet

Metal Ion Chelating Agent Indicator Buffer Analyst
Calcium EDTA EBT pH 10 (NH₄OH buffer) Sunita Reddy

Annexure-2: Reagent Preparation Log

Reagent Strength Standardized Against Date
EDTA 0.05 M Calcium Carbonate 10/05/2025

Annexure-3: Sample Preparation Record

Sample Weight Solvent pH Adjusted
Calcium Gluconate 500 mg Water 10

Annexure-4: Titration Worksheet

Trial EDTA Volume (mL) Calculation % Assay
1 20.35 Formula Applied 99.4%

Annexure-5: Optimization Record

Parameter Variation Observation Conclusion
pH 9.5 Less sharp endpoint Rejected

Annexure-6: Validation Summary Report

Parameter Criteria Result Status
Accuracy 98–102% 99.3% Pass
Precision RSD ≤ 2% 0.84% Pass
Linearity R² ≥ 0.999 0.9991 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded validation criteria and included masking strategies Annual Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Reporting Deviations in IPC Parameters – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version